Bussel JB - Search Results

1

One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximab.

Mueller BU, Bennett CM, Feldman HA, Bussel JB, Abshire TC, Moore TB, Sawaf H, Loh ML, Rogers ZR, Glader BE, McCarthy MC, Mahoney DH, Olson TA, Feig SA, Lorenzana AN, Mentzer WC, Buchanan GR, Neufeld EJ; Pediatric Rituximab/ITP Study Group; Glaser Pediatric Research Network. Mueller BU, et al. Among authors: bussel jb. Pediatr Blood Cancer. 2009 Feb;52(2):259-62. doi: 10.1002/pbc.21757. Pediatr Blood Cancer. 2009. PMID: 18937333 Free PMC article. Clinical Trial.

2

Maintenance treatment of adults with chronic refractory immune thrombocytopenic purpura using repeated intravenous infusions of gammaglobulin.

Bussel JB, Pham LC, Aledort L, Nachman R. Bussel JB, et al. Blood. 1988 Jul;72(1):121-7. Blood. 1988. PMID: 3134063 Free article.

3

Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura.

Bussel JB, Kimberly RP, Inman RD, Schulman I, Cunningham-Rundles C, Cheung N, Smithwick EM, O'Malley J, Barandun S, Hilgartner MW. Bussel JB, et al. Blood. 1983 Aug;62(2):480-6. Blood. 1983. PMID: 6191803 Free article.

4

TTP following ITP in an HIV-positive boy.

Prasad VK, Kim IK, Farrington K, Bussel JB. Prasad VK, et al. Among authors: bussel jb. J Pediatr Hematol Oncol. 1996 Nov;18(4):384-6. doi: 10.1097/00043426-199611000-00010. J Pediatr Hematol Oncol. 1996. PMID: 8888747

5

Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients.

Scaradavou A, Woo B, Woloski BM, Cunningham-Rundles S, Ettinger LJ, Aledort LM, Bussel JB. Scaradavou A, et al. Among authors: bussel jb. Blood. 1997 Apr 15;89(8):2689-700. Blood. 1997. PMID: 9108386 Free article. Clinical Trial.

6

Safety and efficacy of low-dose intravenous immune globulin (IVIG) treatment for infants and children with immune thrombocytopenic purpura. Low-Dose IVIG Study Group.

Warrier I, Bussel JB, Valdez L, Barbosa J, Beardsley DS. Warrier I, et al. Among authors: bussel jb. J Pediatr Hematol Oncol. 1997 May-Jun;19(3):197-201. doi: 10.1097/00043426-199705000-00004. J Pediatr Hematol Oncol. 1997. PMID: 9201140 Clinical Trial.

7

Clinical experience with anti-D in the treatment of idiopathic thrombocytopenic purpura.

Scaradavou A, Bussel JB. Scaradavou A, et al. Among authors: bussel jb. Semin Hematol. 1998 Jan;35(1 Suppl 1):52-7. Semin Hematol. 1998. PMID: 9523749 Review.

8

Splenectomy-sparing strategies for the treatment and long-term maintenance of chronic idiopathic (immune) thrombocytopenic purpura.

Bussel JB. Bussel JB. Semin Hematol. 2000 Jan;37(1 Suppl 1):1-4. doi: 10.1016/s0037-1963(00)90110-0. Semin Hematol. 2000. PMID: 10676916

9

Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy?

Cooper N, Woloski BM, Fodero EM, Novoa M, Leber M, Beer JH, Bussel JB. Cooper N, et al. Among authors: bussel jb. Blood. 2002 Mar 15;99(6):1922-7. doi: 10.1182/blood.v99.6.1922. Blood. 2002. PMID: 11877261 Free article. Clinical Trial.

10

Novel approaches to refractory immune thrombocytopenic purpura.

Bussel JB. Bussel JB. Blood Rev. 2002 Mar;16(1):31-6. doi: 10.1054/blre.2001.0178. Blood Rev. 2002. PMID: 11913991 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

446 results

Search Page

Filters